Another clinical trial has found that SIGA Technologies' antiviral drug tecovirimat is ineffective as a treatment for mpox, prompting the investigators to stop patient recruitment. The study by ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The team at Oxford University behind the landmark RECOVERY trial of COVID-19 therapies now has monkeypox in its sights, with a study that will see if Siga Technologies' smallpox drug Tpoxx can be used ...

Chart does not reflect overnight price.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate SIGA Technologies, Inc. before investing. In this article, we go over a few key ...

See SIGA Technologies, Inc. (SIGA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for medical needs and biothreats. The firm develops ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Abstract: I welcome you to the fourth issue of the IEEE Communications Surveys and Tutorials in 2021. This issue includes 23 papers covering different aspects of communication networks. In particular, ...